JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IMTXW
5451
DELISTED
Immatics N.V. Warrants
IMTXW
| – | – |
0
| – | – |
2021 Q1
13 quarters
|
|
5452
Full House Resorts
FLL
$52M
| $71.7K | ﹤0.01% |
14,345
+1,022
| +8% | +$5.19K |
2021 Q2
12 quarters
|
|
5453
Innovator Buffer Step-Up Strategy ETF
BSTP
$59.3M
| $71.6K | ﹤0.01% |
2,284
| – | – |
2023 Q3
3 quarters
|
|
5454
iShares Core Conservative Allocation ETF
AOK
$812M
| $71.2K | ﹤0.01% |
1,927
-1,345
| -41% | -$49.1K |
2015 Q3
35 quarters
|
|
5455
Quest Resource Holding
QRHC
$28.7M
| $71K | ﹤0.01% |
8,065
+2,059
| +34% | +$19K |
2023 Q3
3 quarters
|
|
5456
CVRx
CVRX
$40.8M
| $70.9K | ﹤0.01% |
5,914
-23,244
| -80% | -$268K |
2023 Q2
4 quarters
|
|
5457
National Bankshares
NKSH
$270M
| $70.6K | ﹤0.01% |
2,497
-6,898
| -73% | -$204K |
2017 Q4
26 quarters
|
|
5458
Bakkt Inc
BKKT
$347M
| $70.6K | ﹤0.01% |
3,732
+2,507
| +205% | +$33.8K |
2021 Q3
11 quarters
|
|
5459
Pyxis Oncology
PYXS
$183M
| $70.5K | ﹤0.01% |
21,312
+20,812
| +4,162% | +$87.5K |
2023 Q1
5 quarters
|
|
5460
Caesarstone
CSTE
$96.1M
| $70.5K | ﹤0.01% |
14,092
+7,683
| +120% | +$43.5K |
2013 Q2
44 quarters
|
|
5461
Cadiz
CDZI
$313M
| $70.5K | ﹤0.01% |
22,801
+5,955
| +35% | +$16.2K |
2023 Q2
4 quarters
|
|
5462
Sera Prognostics
SERA
$80.5M
| $70.2K | ﹤0.01% |
11,865
-46,929
| -80% | -$420K |
2021 Q3
11 quarters
|
|
5463
Lexeo Therapeutics
LXEO
$297M
| $70K | ﹤0.01% |
4,363
-1,590
| -27% | -$23.1K |
2023 Q4
2 quarters
|
|
5464
PIMCO Enhanced Short Maturity Active ESG ETF
EMNT
$235M
| $69.9K | ﹤0.01% |
708
-68
| -9% | -$6.7K |
2023 Q3
3 quarters
|
|
5465
Redwire
RDW
$2.64B
| $69.8K | ﹤0.01% |
9,737
-2,868
| -23% | -$13.8K |
2022 Q2
8 quarters
|
|
5466
CALL
Green Plains
GPRE
$1.05B
| $69.8K | ﹤0.01% |
4,400
| – | – |
2024 Q1
1 quarter
|
|
5467
ProKidney
PROK
$357M
| $69.8K | ﹤0.01% |
28,358
+7,546
| +36% | +$20.3K |
2022 Q4
6 quarters
|
|
5468
Heritage Insurance Holdings
HRTG
$1.01B
| $69.6K | ﹤0.01% |
9,833
-13,312
| -58% | -$118K |
2017 Q2
28 quarters
|
|
5469
Torrid Holdings
CURV
$226M
| $69.1K | ﹤0.01% |
9,225
-16,060
| -64% | -$92K |
2021 Q3
11 quarters
|
|
5470
Invesco DB Base Metals Fund
DBB
$361M
| $69K | ﹤0.01% |
3,428
-6,187
| -64% | -$125K |
2020 Q4
14 quarters
|
|
5471
Virco
VIRC
$103M
| $69K | ﹤0.01% |
+4,952
| New | +$61.4K |
2024 Q2
0 quarters
|
|
5472
Southern California Bancorp
BCAL
$693M
| $69K | ﹤0.01% |
5,124
-9,359
| -65% | -$130K |
2023 Q4
2 quarters
|
|
5473
Achieve Life Sciences
ACHV
$775M
| $69K | ﹤0.01% |
+14,677
| New | +$70.7K |
2024 Q2
0 quarters
|
|
5474
Energy Vault
NRGV
$707M
| $68.4K | ﹤0.01% |
72,001
+4,923
| +7% | +$6.11K |
2021 Q4
10 quarters
|
|
5475
Outdoor Holding Co
POWW
$265M
| $68.3K | ﹤0.01% |
40,629
+2,699
| +7% | +$6.5K |
2021 Q2
12 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.